About: generic medicine
Pharma industry raises the alarm about stockpiling of generic drugs
The industry of innovative medicines is concerned with a recent vote in the European Parliament on the stockpiling of generic drugs, saying that it causes uncertainty over innovation in the pharmaceutical field.Discussion heats up over stockpiling of generic drugs under patent protection
The Commission has announced its intention to add a manufacturing waiver to supplementary protection certificates (SPC), as part of its upgraded 2015 Single Market Strategy.Andriukaitis: SPC manufacturing waiver does not damage pharma innovation
The European Commission’s proposal to add an SPC manufacturing waiver on exports will not damage innovation, as the pharma industry claims, and only intends to support small and medium generic drug companies, according to EU Health Commissioner Vytenis Andriukaitis.OpinionPromoted content